Bozeman, MT, United States of America

Noel Erwin Palmer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Noel Erwin Palmer

Introduction

Noel Erwin Palmer is an accomplished inventor based in Bozeman, MT (US). He has made significant contributions to the field of cannabinoid formulations, holding a total of 3 patents. His work focuses on innovative methods for delivering cannabinoids effectively to users.

Latest Patents

One of his latest patents is centered around transdermal cannabinoid formulations. This invention includes a transdermal composition that contains a pharmaceutically effective amount of a cannabinoid for delivery into the bloodstream of a user. The composition may comprise components such as a surfactant-lecithin organogel and a cannabinoid. Additionally, it may include an exogenous terpene. The cannabinoid is capable of diffusing from the composition into the bloodstream, and it can be utilized in methods for treating various conditions, including pain, nausea, convulsions, muscle spasms, inflammation, depression, and cachexia.

Career Highlights

Throughout his career, Noel has worked with notable companies, including Mary's Medicinals LLC and the Wisconsin Alumni Research Foundation. His experience in these organizations has contributed to his expertise in cannabinoid research and development.

Collaborations

Noel has collaborated with professionals in his field, including Nicole Smith, to further advance his innovative projects.

Conclusion

Noel Erwin Palmer's contributions to cannabinoid formulations demonstrate his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of the therapeutic potential of cannabinoids, paving the way for future advancements in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…